About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Memorial Sloan Kettering Cancer Center
https://www.mskcc.org/healthcare-professionals
Refer a Patient to MSKCC:
mskcc.org/refer
COVID-19
Myeloma
Leukemia
Lymphoma
Hematologic Transplantation and Malignancies
Breast
Lung
Gastrointestinal
Genitourinary
Gynecologic
Skin
Head and Neck
Brain
General Oncology
Palliative Care
Events
MPN
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
Confronting Inequity in Modern Therapy for Rare Melanomas
By
Massachusetts General Hospital Cancer Center
FEATURING
Alexander Shoushtari
By
Massachusetts General Hospital Cancer Center
FEATURING
Alexander Shoushtari
65 views
June 25, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Skin
29:16
Insights from 2023 IGCS Annual Meeting
IGCS 2023 Insights: "Vulvovaginal Melanoma - Current Approaches…
Feat.
M. Leitao
24:53
OncoAlert
Recent Melanoma Updates
Feat.
A. Betof Warner
04:04
GRACE
Clinical Trials in Melanoma
Feat.
M. Postow
02:49
GRACE
Major Advances in Uveal Melanoma
Feat.
M. Postow
04:28
GRACE
BRAF Mutated Melanoma
Feat.
M. Postow
03:10
GRACE
Side Effects of Immunotherapy in Melanoma
Feat.
M. Postow
08:00
GRACE
Immunotherapy in Treatment of Melanoma
Feat.
M. Postow
05:50
GRACE
Melanoma and Current Treatment Options
Feat.
M. Postow
11:42
Memorial Sloan Kettering Cancer Center
Who Should Be Getting Adjuvant Therapy in Melanoma?
Feat.
A. Betof Warner
47:34
Massachusetts General Hospital Cancer Center
Confronting Inequity in Modern Therapy for Rare Melanomas
Feat.
A. Shoushtari
10:11
Memorial Sloan Kettering Cancer Center
2022 Updates in the Treatment of Melanoma
Feat.
M. Postow
06:32
Memorial Sloan Kettering Cancer Center
2021 ASCO Highlights on 1L Treatment for Advanced Melanoma: RELATIVI…
Feat.
A. Betof Warner
15:05
Memorial Sloan Kettering Cancer Center
2020 Updates on Stage 4 Melanoma: Do BRAF+ MEK Combos Improve PFS? I…
Feat.
A. Betof Warner
13:02
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer
Skin Toxicities are First and Frequent in Immunotherapy
Feat.
M. Lacouture
14:10
Weill Cornell Medicine Courses and Meetings
Systemic Therapy for Melanoma Brain Metastases: RAF/MEK Inhibitors a…
Feat.
P. Chapman
